Arcus Biosciences RCUS Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's total operating expenses?
- Arcus Biosciences (RCUS) reported total operating expenses of $151M in Q1 2026.
- How has Arcus Biosciences's total operating expenses changed year-over-year?
- Arcus Biosciences's total operating expenses increased by 0.7% year-over-year, from $150M to $151M.
- What is the long-term trend for Arcus Biosciences's total operating expenses?
- Over 4 years (2021 to 2025), Arcus Biosciences's total operating expenses has grown at a 17.8% compound annual growth rate (CAGR), from $329M to $633M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.